Reduced Clearance of Phenobarbital in Advanced Cancer Patients near the End of Life

ConclusionTerminally ill patients with advanced cancer may have reduced CLPB, thereby TDM is recommended for these patients particularly near the end of life.
Source: European Journal of Drug Metabolism and Pharmacokinetics - Category: Drugs & Pharmacology Source Type: research